Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Merck
Moodys
Baxter
Johnson and Johnson

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Hetero Labs Ltd V Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for HETERO LABS LTD V, and what generic and branded alternatives to HETERO LABS LTD V drugs are available?

HETERO LABS LTD V has twenty-four approved drugs.

There are five tentative approvals on HETERO LABS LTD V drugs.

Summary for Hetero Labs Ltd V
US Patents:0
Tradenames:22
Ingredients:21
NDAs:24

Drugs and US Patents for Hetero Labs Ltd V

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hetero Labs Ltd V LAMIVUDINE lamivudine TABLET;ORAL 203277-001 Jan 6, 2014 AB RX No No   See Pricing   See Pricing
Hetero Labs Ltd V PANTOPRAZOLE SODIUM pantoprazole sodium TABLET, DELAYED RELEASE;ORAL 202882-001 Sep 10, 2014 AB RX No No   See Pricing   See Pricing
Hetero Labs Ltd V ROSUVASTATIN CALCIUM rosuvastatin calcium TABLET;ORAL 207616-004 Oct 31, 2016 AB RX No No   See Pricing   See Pricing
Hetero Labs Ltd V DONEPEZIL HYDROCHLORIDE donepezil hydrochloride TABLET;ORAL 203034-001 Jan 30, 2015 AB RX No No   See Pricing   See Pricing
Hetero Labs Ltd V MONTELUKAST SODIUM montelukast sodium TABLET;ORAL 202843-001 Sep 10, 2014 AB RX No No   See Pricing   See Pricing
Hetero Labs Ltd V ENTECAVIR entecavir TABLET;ORAL 205740-001 Aug 21, 2015 AB RX No No   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Colorcon
Express Scripts
Merck
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.